Sign in
bf/NASDAQ:SABS_icon.jpeg

NASDAQ:SABS

SAB Biotherapeutics, Inc.

  • Stock

USD

Last Close

2.76

26/07 20:00

Market Cap

29.53M

Beta: 1.26

Volume Today

2.99K

Avg: 1.39M

PE Ratio

−10.36

PFCF: 7.38

OverviewFinancialsFilingspeopleOwnershipAPIChartData
Income StatementBalance SheetCash FlowKey MetricsRatios
Excel Tearsheet
Quarterly
Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
asset turnover
0.19
-
0.98
411.06%
0.77
21.49%
0.47
38.78%
0.03
94.32%
cash conversion cycle
-92.19
-
cash per share
0.15
-
0.29
98.71%
1.21
318.74%
0.35
71.54%
10.24
2,863.41%
company equity multiplier
-7.81
-
1.45
118.56%
2.06
42.05%
1.64
20.39%
1.46
10.62%
days of inventory outstanding
days of payables outstanding
92.19
-
days of sales outstanding
298.92
-
135.92
54.53%
48.03
64.66%
84.85
76.65%
dividend yield
ebit per revenue
-2.52
-
0.37
114.77%
-0.22
159.12%
-1.21
449.86%
-17.01
1,305.73%
ebt per ebit
1.04
-
0.98
5.54%
1.28
30.80%
0.65
49.44%
1.11
71.23%
effective tax rate
-0.05
-
0.02
149.03%
-0.02
174.39%
-0.00
92.17%
0.00
100.00%
enterprise value multiple
-53.75
-
20.67
138.45%
-15.97
177.29%
-0.61
96.18%
0.37
160.54%
fixed asset turnover
0.39
-
2.50
533.36%
1.97
21.36%
0.84
57.12%
0.09
89.25%
free cash flow per share
-0.23
-
-0.06
72.24%
-0.26
319.00%
-0.17
37.19%
-4.59
2,677.51%
gross profit margin
1
-
1
0%
1
0%
1
0%
-0.67
167.28%
interest coverage
-20.24
-
43.82
316.46%
-45.48
203.80%
-95.89
110.81%
120.77
225.95%
inventory turnover
long term debt to capitalization
1.68
-
0.14
91.54%
0.12
13.40%
0.13
3.39%
0.07
48.11%
net income per ebt
1.05
-
1
4.58%
1.02
1.75%
1.00
1.58%
1
0.14%
net profit margin
-2.74
-
0.36
113.31%
-0.29
178.68%
-0.78
173.59%
-18.85
2,303.71%
operating cash flow per share
-0.21
-
0.23
208.58%
0.14
40.26%
0.09
37.19%
-4.55
5,368.26%
operating cycle
operating profit margin
-2.52
-
0.37
114.77%
-0.22
159.12%
-1.21
449.86%
-17.01
1,305.73%
payables turnover
3.96
-
pretax profit margin
-2.61
-
0.36
113.95%
-0.28
177.33%
-0.78
178.00%
-18.85
2,307.00%
price fair value
-191.39
-
11.31
105.91%
5.54
51.04%
0.83
85.07%
0.66
19.80%
receivables turnover
1.22
-
2.69
119.93%
7.60
182.98%
4.30
43.39%
return on assets
-0.52
-
0.36
168.03%
-0.22
161.77%
-0.37
67.50%
-0.50
36.54%
return on capital employed
-0.65
-
0.45
169.76%
-0.24
154.18%
-0.81
228.79%
-0.52
35.34%
return on equity
4.08
-
0.52
87.37%
-0.45
187.74%
-0.60
33.35%
-0.74
22.04%
total debt to capitalization
1.43
-
0.17
87.96%
0.15
13.64%
0.16
7.65%
0.09
41.70%

All numbers in USD (except ratios and percentages)